Hudspeth Victoria Rollins, Gold Stuart Harrison, Clemmons David Robert
Endocr Pract. 2017 Dec;23(12):1394-1401. doi: 10.4158/EP-2017-0033. Epub 2017 Nov 16.
The 5-year survival rate for childhood cancer has increased to 80%, resulting in a growing population of adult survivors of childhood cancer (ASOCC). Long-term endocrine dysfunction is as high as 63% when screened in research protocols. The purpose of this study was to evaluate the prevalence of endocrine testing, endocrine dysfunction, diabetes, obesity, and endocrinologist visits outside of a research screening protocol.
A retrospective chart review was performed for 176 ASOCC who were diagnosed with cancer before age 18, followed at least 10 years, were now at least 18, and had survived to the time of chart review.
After a mean follow-up of 15.2 years (range 10-21 years), 33.5% of ASOCC had endocrine dysfunction, excluding obesity and diabetes. These outcomes were more common in those with any radiation (64.8%, P<.0001) or cranial radiation (73.1%, P<.0001). Many subjects had never had certain endocrine tests. Over half (54.6%) of subjects were either overweight or obese. Glycated hemoglobin A1C (A1C) testing was rare, but when performed, 38.1% were abnormal. 71% of subjects had never seen an endocrinologist. Even among subjects with cranial radiation, 65.4% had either never seen an endocrinologist or had not seen one in the past 5 years.
This cohort of ASOCC showed high rates of endocrine dysfunction, overweight or obesity, and diabetes in those who had been tested, combined with low rates of testing and endocrinology evaluation. Endocrinologists need to be aware of the endocrine risks in ASOCC, the need for long-term monitoring, and increase their collaboration with oncology.
A1C = glycated hemoglobin A1C ASOCC = adult survivors of childhood cancer BMI = body mass index COG = Children's Oncology Group EMR = electronic medical record FSH = follicle-stimulating hormone IGF-1 = insulin-like growth factor 1 LH = luteinizing hormone TSH = thyroid-stimulating hormone.
儿童癌症的5年生存率已提高到80%,导致儿童癌症成年幸存者(ASOCC)群体不断增加。在研究方案筛查中,长期内分泌功能障碍高达63%。本研究的目的是评估在研究筛查方案之外进行内分泌检测、内分泌功能障碍、糖尿病、肥胖以及内分泌科就诊的患病率。
对176例18岁前被诊断患有癌症、至少随访10年、现至少18岁且存活至病历审查时的ASOCC进行回顾性病历审查。
平均随访15.2年(范围10 - 21年)后,33.5%的ASOCC存在内分泌功能障碍,不包括肥胖和糖尿病。这些结果在接受过任何放疗(64.8%,P <.0001)或颅脑放疗(73.1%,P <.0001)的患者中更为常见。许多受试者从未进行过某些内分泌检测。超过一半(54.6%)的受试者超重或肥胖。糖化血红蛋白A1C(A1C)检测很少见,但进行检测时,38.1%异常。71%的受试者从未看过内分泌科医生。即使在接受过颅脑放疗的受试者中,65.4%要么从未看过内分泌科医生,要么在过去5年中未看过。
这组ASOCC显示出内分泌功能障碍、超重或肥胖以及已检测者中糖尿病的发生率较高,但检测率和内分泌科评估率较低。内分泌科医生需要了解ASOCC中的内分泌风险、长期监测的必要性,并加强与肿瘤科的合作。
A1C = 糖化血红蛋白A1C;ASOCC = 儿童癌症成年幸存者;BMI = 体重指数;COG = 儿童肿瘤学组;EMR = 电子病历;FSH = 促卵泡激素;IGF - 1 = 胰岛素样生长因子1;LH = 促黄体生成素;TSH = 促甲状腺激素